Kathleen S. Wright Associates’s Diageo DEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$165K Buy
1,725
+885
+105% +$92.9K 0.06% 112
2025
Q2
$84.7K Sell
840
-100
-11% -$10.8K 0.03% 131
2025
Q1
$98.5K Sell
940
-2,875
-75% -$325K 0.04% 127
2024
Q4
$485K Sell
3,815
-130
-3% -$16.5K 0.2% 79
2024
Q3
$554K Buy
3,945
+400
+11% +$52K 0.23% 70
2024
Q2
$447K Sell
3,545
-500
-12% -$68.9K 0.21% 76
2024
Q1
$602K Buy
4,045
+330
+9% +$48.3K 0.28% 65
2023
Q4
$541K Hold
3,715
0.28% 65
2023
Q3
$554K Buy
3,715
+400
+12% +$67K 0.31% 64
2023
Q2
$575K Sell
3,315
-3,435
-51% -$613K 0.37% 57
2023
Q1
$1.22M Sell
6,750
-50
-0.7% -$8.82K 0.8% 33
2022
Q4
$1.21M Buy
6,800
+185
+3% +$32.5K 0.82% 35
2022
Q3
$1.12M Buy
6,615
+890
+16% +$159K 0.91% 34
2022
Q2
$997K Hold
5,725
0.84% 34
2022
Q1
$1.16M Buy
5,725
+30
+0.5% +$6.01K 0.85% 33
2021
Q4
$1.25M Buy
+5,695
New +$1.17M 0.92% 30

Other funds holding DEO

Kathleen S. Wright Associates's DEO Position: Q3 2025 in Review

Kathleen S. Wright Associates increased its Diageo (DEO) stake by 105% in Q3 2025, buying an estimated $92.9K and bringing the position to 1,725 shares worth $165K. The position accounts for 0.06% of the portfolio, ranked #112.

Kathleen S. Wright Associates first reported a position in DEO in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.25M in Q4 2021. 823 funds tracked by Wall St. Rank hold DEO as of Q3 2025.

  • Kathleen S. Wright Associates held 1,725 shares of Diageo worth $165K as of Q3 2025.
  • Kathleen S. Wright Associates bought 885 Diageo shares in Q3 2025, an estimated $92.9K.
  • Diageo made up 0.06% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #112 holding.
  • Kathleen S. Wright Associates first reported a position in Diageo in Q4 2021 and has held it in 16 quarters since.
  • Kathleen S. Wright Associates's Diageo position peaked at $1.25M in Q4 2021.
  • 823 funds tracked by Wall St. Rank held Diageo as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.